Poland· PL-100349231
Osaver HCT
A olmesartan medoxomil product containing olmesartanum medoxomilum + hydrochlorothiazidum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil is registered in 15 of 19 countries.
Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Olmesartan medoxomil · ATC C09CA08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of olmesartan medoxomil costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olmesartan medoxomil · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.86
- ES Spain$0.41
- IT Italy$0.33
The record
At a glance
URPL (Poland)- Active substance
- Olmesartanum medoxomilum + Hydrochlorothiazidum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- C09CA08
- ATC class
- Olmesartan medoxomil
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
- gtin05909991276874
- gtin05909991276881
- gtin05909991276898
- gtin05909991276904
- gtin05909991276911
- gtin05909991276928
- gtin05909991276935
- gtin05909991276942
- gtin05909991276959
- gtin05909991276966
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
216 interactions on record for olmesartan medoxomil.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil · interactions on record
216 records
- 7 severe
- 128 moderate
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olmesartan medoxomil in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b13d33ba-7c34-4e1b-b75e-8e7d2018d9af GET /v1/drugs/b13d33ba-7c34-4e1b-b75e-8e7d2018d9af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg + 12,5 mg",
"packaging": "05909991276874 ¦ Rp ¦ 115923\n14 tabl.\n05909991276881 ¦ Rp ¦ 115924\n28 tabl.\n05909991276898 ¦ Rp ¦ 115925\n30 tabl.\n05909991276904 ¦ Rp ¦ 115926\n50 tabl.\n05909991276911 ¦ Rp ¦ 115927\n56 tabl.\n05909991276928 ¦ Rp ¦ 115928\n84 tabl.\n05909991276935 ¦ Rp ¦ 115929\n90 tabl.\n05909991276942 ¦ Rp ¦ 115930\n98 tabl.\n05909991276959 ¦ Rp ¦ 115931\n100 tabl.\n05909991276966 ¦ Rp ¦ 115932\n500 tabl.",
"substance": "Olmesartanum medoxomilum 40 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Olmesartanum medoxomilum + Hydrochlorothiazidum",
"pl_product_id": "100349231",
"pozwolenie_nr": "23214",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about olmesartan medoxomil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.